<s id="wsj_0339.1"> 26
4 	 1 	 (S/S)/NP 	 2 	 year During
4 	 2 	 NP[nb]/N 	 1 	 year its
4 	 3 	 N/N 	 1 	 year centennial
9 	 6 	 NP[nb]/N 	 1 	 Journal The
9 	 7 	 N/N 	 1 	 Journal Wall
9 	 8 	 N/N 	 1 	 Journal Street
9 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Journal will
9 	 11 	 (S[b]\NP)/NP 	 1 	 Journal report <XB>
10 	 1 	 (S/S)/NP 	 1 	 will During
11 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 report will
12 	 11 	 (S[b]\NP)/NP 	 2 	 events report
12 	 13 	 (NP\NP)/NP 	 1 	 events of
12 	 17 	 (NP\NP)/(S[dcl]\NP) 	 1 	 events that
12 	 18 	 (S[dcl]\NP)/PP 	 1 	 events stand <XB>
16 	 13 	 (NP\NP)/NP 	 2 	 century of
16 	 14 	 NP[nb]/N 	 1 	 century the
16 	 15 	 N/N 	 1 	 century past
18 	 17 	 (NP\NP)/(S[dcl]\NP) 	 2 	 stand that
19 	 18 	 (S[dcl]\NP)/PP 	 2 	 as stand
20 	 19 	 PP/NP 	 1 	 milestones as
20 	 21 	 (NP\NP)/NP 	 1 	 milestones of
24 	 21 	 (NP\NP)/NP 	 2 	 history of
24 	 22 	 N/N 	 1 	 history American
24 	 23 	 N/N 	 1 	 history business
<\s>
<s id="wsj_0339.2"> 10
1 	 0 	 N/N 	 1 	 BURBANK LUTHER
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 BURBANK CROSS-BRED
1 	 5 	 (S[b]\NP)/NP 	 1 	 BURBANK produce <XB>
3 	 2 	 (S[dcl]\NP)/NP 	 2 	 PLANTS CROSS-BRED
5 	 4 	 (S[to]\NP)/(S[b]\NP) 	 2 	 produce to
9 	 5 	 (S[b]\NP)/NP 	 2 	 potato produce
9 	 6 	 NP[nb]/N 	 1 	 potato the
9 	 7 	 N/N 	 1 	 potato billion-dollar
9 	 8 	 N/N 	 1 	 potato Idaho
<\s>
<s id="wsj_0339.3"> 16
0 	 1 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 Bioengineers set
0 	 4 	 (S[b]\NP)/NP 	 1 	 Bioengineers duplicate <XB>
0 	 8 	 S[adj]\NP 	 1 	 Bioengineers scientifically <XB>
0 	 10 	 S[adj]\NP 	 1 	 Bioengineers commercially <XU>
1 	 2 	 (S\NP)\(S\NP) 	 2 	 set out
3 	 1 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to set
4 	 3 	 (S[to]\NP)/(S[b]\NP) 	 2 	 duplicate to
4 	 7 	 ((S\NP)\(S\NP))/(S[adj]\NP) 	 2 	 duplicate --
4 	 12 	 ((S\NP)\(S\NP))/NP 	 2 	 duplicate with
6 	 4 	 (S[b]\NP)/NP 	 2 	 feat duplicate
6 	 5 	 NP[nb]/N 	 1 	 feat that
8 	 7 	 ((S\NP)\(S\NP))/(S[adj]\NP) 	 3 	 scientifically --
10 	 7 	 ((S\NP)\(S\NP))/(S[adj]\NP) 	 3 	 commercially --
15 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 forms with
15 	 13 	 N/N 	 1 	 forms new
15 	 14 	 N/N 	 1 	 forms life
<\s>
<s id="wsj_0339.4"> 24
1 	 0 	 (S/S)/NP 	 2 	 1953 In
4 	 3 	 N/N 	 1 	 Watson James
4 	 8 	 (S[dcl]\NP)/NP 	 1 	 Watson unlocked
7 	 6 	 NP[nb]/N 	 1 	 colleagues his
7 	 8 	 (S[dcl]\NP)/NP 	 1 	 colleagues unlocked
8 	 0 	 (S/S)/NP 	 1 	 unlocked In
11 	 8 	 (S[dcl]\NP)/NP 	 2 	 helix unlocked
11 	 9 	 NP[nb]/N 	 1 	 helix the
11 	 10 	 N/N 	 1 	 helix double
11 	 12 	 (NP\NP)/NP 	 1 	 helix of
13 	 12 	 (NP\NP)/NP 	 2 	 DNA of
13 	 14 	 (NP\NP)/NP 	 1 	 DNA -LRB-
16 	 14 	 (NP\NP)/NP 	 2 	 acid -LRB-
16 	 15 	 N/N 	 1 	 acid deoxyribonucleic
21 	 12 	 (NP\NP)/NP 	 2 	 key of
21 	 19 	 NP[nb]/N 	 1 	 key the
21 	 20 	 N/N 	 1 	 key genetic
21 	 22 	 (NP\NP)/NP 	 1 	 key to
23 	 22 	 (NP\NP)/NP 	 2 	 heredity to
<\s>
<s id="wsj_0339.5"> 31
1 	 0 	 N/N 	 1 	 years Twenty
1 	 2 	 (S/S)\NP 	 2 	 years later
6 	 4 	 N/N 	 1 	 academics two
6 	 5 	 N/N 	 1 	 academics California
6 	 14 	 (S[dcl]\NP)/NP 	 1 	 academics made
6 	 18 	 ((S[ng]\NP)/PP)/NP 	 1 	 academics transplanting <XB>
9 	 8 	 N/N 	 1 	 Cohen Stanley
9 	 14 	 (S[dcl]\NP)/NP 	 1 	 Cohen made
9 	 18 	 ((S[ng]\NP)/PP)/NP 	 1 	 Cohen transplanting <XB>
12 	 11 	 N/N 	 1 	 Boyer Herbert
12 	 14 	 (S[dcl]\NP)/NP 	 1 	 Boyer made
12 	 18 	 ((S[ng]\NP)/PP)/NP 	 1 	 Boyer transplanting <XB>
14 	 2 	 (S/S)\NP 	 1 	 made later
16 	 14 	 (S[dcl]\NP)/NP 	 2 	 DNA made
16 	 15 	 N/N 	 1 	 DNA recombinant
20 	 19 	 NP[nb]/N 	 1 	 toad a
20 	 21 	 (NP[nb]/N)\NP 	 2 	 toad 's
22 	 18 	 ((S[ng]\NP)/PP)/NP 	 3 	 gene transplanting
22 	 21 	 (NP[nb]/N)\NP 	 1 	 gene 's
23 	 18 	 ((S[ng]\NP)/PP)/NP 	 2 	 into transplanting
24 	 23 	 PP/NP 	 1 	 bacteria into
24 	 26 	 (NP\NP)/(S[dcl]\NP) 	 1 	 bacteria which
24 	 28 	 (S[dcl]\NP)/NP 	 1 	 bacteria reproduced <XB>
28 	 26 	 (NP\NP)/(S[dcl]\NP) 	 2 	 reproduced which
28 	 27 	 (S\NP)/(S\NP) 	 2 	 reproduced then
30 	 28 	 (S[dcl]\NP)/NP 	 2 	 genes reproduced
30 	 29 	 N/N 	 1 	 genes toad
<\s>
<s id="wsj_0339.6"> 16
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 Boyer met
2 	 0 	 (S/S)/S[dcl] 	 2 	 met When
2 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 met in
4 	 2 	 (S[dcl]\NP)/NP 	 2 	 Swanson met
4 	 3 	 N/N 	 1 	 Swanson Robert
8 	 2 	 (S[dcl]\NP)/NP 	 2 	 chemist-turned-entrepreneur met
8 	 6 	 NP[nb]/N 	 1 	 chemist-turned-entrepreneur an
8 	 7 	 N/N 	 1 	 chemist-turned-entrepreneur M.I.T.-trained
10 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 1976 in
12 	 13 	 (S[dcl]\NP)/NP 	 1 	 they saw
13 	 0 	 (S/S)/S[dcl] 	 1 	 saw When
15 	 13 	 (S[dcl]\NP)/NP 	 2 	 signs saw
15 	 14 	 N/N 	 1 	 signs dollar
<\s>
<s id="wsj_0339.7"> 15
1 	 0 	 (S/S)/NP 	 2 	 $ With
1 	 3 	 NP\NP 	 1 	 $ apiece
2 	 1 	 N/N[num] 	 1 	 500 $
6 	 0 	 (S/S)/NP 	 2 	 injection With
6 	 5 	 NP[nb]/N 	 1 	 injection an
6 	 7 	 (NP\NP)/NP 	 1 	 injection of
9 	 7 	 (NP\NP)/NP 	 2 	 capital of
9 	 8 	 N/N 	 1 	 capital outside
11 	 12 	 (S[dcl]\NP)/NP 	 1 	 they formed
12 	 0 	 (S/S)/NP 	 1 	 formed With
14 	 12 	 (S[dcl]\NP)/NP 	 2 	 Inc formed
14 	 13 	 N/N 	 1 	 Inc Genentech
<\s>
<s id="wsj_0339.8"> 4
1 	 0 	 N/N 	 1 	 gene-splicing Commercial
1 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 gene-splicing was
1 	 3 	 S[pss]\NP 	 1 	 gene-splicing born <XB>
3 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 born was
<\s>
<s id="wsj_0339.9"> 14
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Genentech 's
3 	 1 	 (NP[nb]/N)\NP 	 1 	 product 's
3 	 2 	 N/N 	 1 	 product first
3 	 11 	 (S[dcl]\NP)/NP 	 1 	 product proved
7 	 5 	 NP[nb]/N 	 1 	 protein a
7 	 6 	 N/N 	 1 	 protein brain
7 	 8 	 (S[pss]\NP)/NP 	 1 	 protein called <XB>
7 	 11 	 (S[dcl]\NP)/NP 	 1 	 protein proved
9 	 8 	 (S[pss]\NP)/NP 	 2 	 somatostatin called
13 	 11 	 (S[dcl]\NP)/NP 	 2 	 technology proved
13 	 12 	 NP[nb]/N 	 1 	 technology its
<\s>
<s id="wsj_0339.10"> 33
1 	 0 	 NP[nb]/N 	 1 	 next The
1 	 9 	 (S[dcl]\NP)/NP 	 1 	 next had
3 	 2 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
4 	 3 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 cloned be
7 	 6 	 N/N 	 1 	 insulin human
7 	 9 	 (S[dcl]\NP)/NP 	 1 	 insulin had
11 	 9 	 (S[dcl]\NP)/NP 	 2 	 potential had
11 	 10 	 N/N 	 1 	 potential market
13 	 14 	 ((S[dcl]\NP)/PP)/NP 	 1 	 Genentech licensed
15 	 14 	 ((S[dcl]\NP)/PP)/NP 	 3 	 it licensed
16 	 14 	 ((S[dcl]\NP)/PP)/NP 	 2 	 to licensed
18 	 16 	 PP/NP 	 1 	 Lilly to
18 	 17 	 N/N 	 1 	 Lilly Eli
18 	 20 	 (NP\NP)/(S[dcl]\NP) 	 1 	 Lilly which
18 	 21 	 (S[dcl]\NP)/NP 	 1 	 Lilly produced <XB>
21 	 20 	 (NP\NP)/(S[dcl]\NP) 	 2 	 produced which
23 	 21 	 (S[dcl]\NP)/NP 	 2 	 % produced
23 	 22 	 N/N 	 1 	 % 80
23 	 24 	 (NP\NP)/NP 	 1 	 % of
26 	 24 	 (NP\NP)/NP 	 2 	 insulin of
26 	 25 	 NP[nb]/N 	 1 	 insulin the
26 	 27 	 S[pss]\NP 	 1 	 insulin used <XB>
27 	 28 	 ((S\NP)\(S\NP))/NP 	 2 	 used by
30 	 29 	 (N/N)/(N/N) 	 2 	 million 1.5
32 	 28 	 ((S\NP)\(S\NP))/NP 	 3 	 diabetics by
32 	 30 	 N/N 	 1 	 diabetics million
32 	 31 	 N/N 	 1 	 diabetics U.S.
<\s>
<s id="wsj_0339.11"> 14
2 	 0 	 NP[nb]/N 	 1 	 credentials Their
2 	 1 	 N/N 	 1 	 credentials laboratory
2 	 3 	 S[pss]\NP 	 1 	 credentials established
5 	 8 	 S[dcl]\NP 	 1 	 Boyer headed
7 	 8 	 S[dcl]\NP 	 1 	 Swanson headed
8 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 headed for
8 	 12 	 ((S\NP)\(S\NP))/NP 	 2 	 headed in
11 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 Street for
11 	 10 	 N/N 	 1 	 Street Wall
13 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 1980 in
<\s>
<s id="wsj_0339.12"> 35
2 	 0 	 (S/S)/NP 	 2 	 time At
2 	 1 	 NP[nb]/N 	 1 	 time the
4 	 5 	 (S[dcl]\NP)/NP 	 1 	 Genentech had
5 	 0 	 (S/S)/NP 	 1 	 had At
7 	 6 	 (N/N)/(N/N) 	 2 	 one only
9 	 5 	 (S[dcl]\NP)/NP 	 2 	 year had
9 	 7 	 N/N 	 1 	 year one
9 	 8 	 N/N 	 1 	 year profitable
9 	 10 	 (NP\NP)/NP 	 1 	 year behind
9 	 12 	 (NP\NP)/NP 	 1 	 year -LRB-
11 	 10 	 (NP\NP)/NP 	 2 	 it behind
15 	 12 	 (NP\NP)/NP 	 2 	 $ -LRB-
15 	 13 	 NP[nb]/N 	 1 	 $ a
15 	 14 	 N/N 	 1 	 $ modest
15 	 17 	 (NP\NP)/NP 	 1 	 $ on
16 	 15 	 N/N[num] 	 1 	 116,000 $
18 	 17 	 (NP\NP)/NP 	 2 	 revenue on
18 	 19 	 (NP\NP)/NP 	 1 	 revenue of
18 	 23 	 (NP\NP)/NP 	 1 	 revenue in
20 	 19 	 (NP\NP)/NP 	 2 	 $ of
22 	 20 	 N/N[num] 	 1 	 million $
22 	 21 	 N/N 	 1 	 million 2.6
24 	 23 	 (NP\NP)/NP 	 2 	 1979 in
28 	 5 	 (S[dcl]\NP)/NP 	 2 	 product had
28 	 27 	 NP[nb]/N 	 1 	 product no
28 	 29 	 (NP\NP)/NP 	 1 	 product of
28 	 32 	 (NP\NP)/NP 	 1 	 product on
31 	 29 	 (NP\NP)/NP 	 2 	 own of
31 	 30 	 NP[nb]/N 	 1 	 own its
34 	 32 	 (NP\NP)/NP 	 2 	 market on
34 	 33 	 NP[nb]/N 	 1 	 market the
<\s>
<s id="wsj_0339.13"> 23
5 	 3 	 (N/N)/N[num] 	 2 	 million $
5 	 4 	 N/N 	 1 	 million 36
6 	 2 	 NP[nb]/N 	 1 	 issue the
6 	 3 	 (N/N)/N[num] 	 1 	 issue $
6 	 8 	 (S[dcl]\NP)/NP 	 2 	 issue floated <XU>
6 	 11 	 (S[dcl]\NP)/PP 	 1 	 issue opened
6 	 16 	 S[dcl]\NP 	 1 	 issue leaped <XU>
7 	 8 	 (S[dcl]\NP)/NP 	 1 	 they floated
8 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 floated in
10 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 1980 in
11 	 0 	 S/S 	 1 	 opened Nonetheless
12 	 11 	 (S[dcl]\NP)/PP 	 2 	 at opened
13 	 12 	 PP/NP 	 1 	 $ at
14 	 13 	 N/N[num] 	 1 	 35 $
16 	 0 	 S/S 	 1 	 leaped Nonetheless
16 	 17 	 ((S\NP)\(S\NP))/NP 	 2 	 leaped to
16 	 20 	 ((S\NP)\(S\NP))/NP 	 2 	 leaped within
18 	 17 	 ((S\NP)\(S\NP))/NP 	 3 	 $ to
19 	 18 	 N/N[num] 	 1 	 89 $
22 	 20 	 ((S\NP)\(S\NP))/NP 	 3 	 minutes within
22 	 21 	 N/N 	 1 	 minutes 20
<\s>
<s id="wsj_0339.14"> 10
1 	 0 	 NP[nb]/N 	 1 	 trip The
1 	 2 	 (NP\NP)/NP 	 1 	 trip from
1 	 6 	 (S[dcl]\NP)/PP 	 1 	 trip was
5 	 2 	 (NP\NP)/NP 	 2 	 tube from
5 	 3 	 NP[nb]/N 	 1 	 tube the
5 	 4 	 N/N 	 1 	 tube test
6 	 7 	 (S\NP)\(S\NP) 	 2 	 was not
8 	 6 	 (S[dcl]\NP)/PP 	 2 	 without was
9 	 8 	 PP/NP 	 1 	 snags without
<\s>
<s id="wsj_0339.16"> 33
1 	 0 	 NP[nb]/N 	 1 	 judgment That
1 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 judgment was
1 	 7 	 S[pss]\NP 	 1 	 judgment reversed <XB>
1 	 14 	 ((S[ng]\NP)/(S[ng]\NP))/NP 	 1 	 judgment leaving <XB>
4 	 3 	 ((S\NP)/(S\NP))/NP 	 3 	 turn in
6 	 3 	 ((S\NP)/(S\NP))/NP 	 2 	 was in
7 	 6 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 reversed was
7 	 8 	 ((S\NP)\(S\NP))/NP 	 2 	 reversed by
12 	 8 	 ((S\NP)\(S\NP))/NP 	 3 	 Court by
12 	 9 	 NP[nb]/N 	 1 	 Court the
12 	 10 	 N/N 	 1 	 Court U.S.
12 	 11 	 N/N 	 1 	 Court Supreme
15 	 14 	 ((S[ng]\NP)/(S[ng]\NP))/NP 	 3 	 Cohen leaving
15 	 18 	 (S[ng]\NP)/NP 	 1 	 Cohen holding <XB>
17 	 14 	 ((S[ng]\NP)/(S[ng]\NP))/NP 	 3 	 Boyer leaving
17 	 18 	 (S[ng]\NP)/NP 	 1 	 Boyer holding <XB>
18 	 14 	 ((S[ng]\NP)/(S[ng]\NP))/NP 	 2 	 holding leaving
21 	 18 	 (S[ng]\NP)/NP 	 2 	 patents holding
21 	 19 	 NP[nb]/N 	 1 	 patents the
21 	 20 	 N/N 	 1 	 patents first
21 	 22 	 (NP\NP)/(S[ng]\NP) 	 1 	 patents for
21 	 26 	 (NP\NP)/(S[dcl]\NP) 	 1 	 patents -LRB-
21 	 28 	 (S[dcl]\NP)/PP 	 1 	 patents assigned <XB>
23 	 22 	 (NP\NP)/(S[ng]\NP) 	 2 	 making for
25 	 23 	 (S[ng]\NP)/NP 	 2 	 DNA making
25 	 24 	 N/N 	 1 	 DNA recombinant
28 	 26 	 (NP\NP)/(S[dcl]\NP) 	 2 	 assigned -LRB-
28 	 27 	 (S\NP)/(S\NP) 	 2 	 assigned now
29 	 28 	 (S[dcl]\NP)/PP 	 2 	 to assigned
31 	 29 	 PP/NP 	 1 	 schools to
31 	 30 	 NP[nb]/N 	 1 	 schools their
<\s>
<s id="wsj_0339.17"> 10
0 	 2 	 (S[dcl]\NP)/NP 	 1 	 Gene-splicing is
2 	 1 	 (S\NP)/(S\NP) 	 2 	 is now
5 	 2 	 (S[dcl]\NP)/NP 	 2 	 part is
5 	 3 	 NP[nb]/N 	 1 	 part an
5 	 4 	 N/N 	 1 	 part integral
5 	 6 	 (NP\NP)/NP 	 1 	 part of
9 	 6 	 (NP\NP)/NP 	 2 	 business of
9 	 7 	 NP[nb]/N 	 1 	 business the
9 	 8 	 N/N 	 1 	 business drug
<\s>
<s id="wsj_0339.18"> 16
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Genentech 's
3 	 1 	 (NP[nb]/N)\NP 	 1 	 sales 's
3 	 2 	 N/N 	 1 	 sales 1988
3 	 4 	 (S[dcl]\NP)/NP 	 1 	 sales were
4 	 10 	 (((S\NP)\(S\NP))/NP)/NP 	 2 	 were from
5 	 4 	 (S[dcl]\NP)/NP 	 2 	 $ were
7 	 5 	 N/N[num] 	 1 	 million $
7 	 6 	 N/N 	 1 	 million 335
10 	 9 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 from both
11 	 10 	 (((S\NP)\(S\NP))/NP)/NP 	 4 	 licensing from
15 	 10 	 (((S\NP)\(S\NP))/NP)/NP 	 3 	 products from
15 	 13 	 NP[nb]/N 	 1 	 products its
15 	 14 	 N/N 	 1 	 products own
<\s>
